CPG
DARE icon

Cornerstone Planning Group’s Dare Bioscience DARE Stock Holding History

Cornerstone Planning Group’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$4 – 1845
2025
Q4 		$4 Sell
2
-245
-99% -$489 ﹤0.01% 1703
2025
Q3 		$38.8K Buy
247
+245
+12,250% +$552 0.01% 398
2025
Q2 		$5 Hold
2
– – ﹤0.01% 1520
2025
Q1 		$6 Hold
2
– – ﹤0.01% 1540
2024
Q4 		$7 Hold
2
– – ﹤0.01% 1388
2024
Q3 		$8 Buy
+2
New +$7 ﹤0.01% 1287
2024
Q2 		– Sell
-1
Closed -$5 – 1243
2024
Q1 		$5 Hold
1
– – ﹤0.01% 1092
2023
Q4 		$5 Hold
1
– – ﹤0.01% 954
2023
Q3 		$7 Buy
+1
New +$8 ﹤0.01% 1197

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Planning Group's DARE Position: Q1 2026 in Review

Cornerstone Planning Group sold out of Dare Bioscience (DARE) in Q1 2026, closing a stake of 2 shares — an estimated $4 sold.

Cornerstone Planning Group first reported a position in DARE in Q3 2023 and held it in 9 quarters. The position peaked at $38.8K in Q3 2025. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • Cornerstone Planning Group reported no remaining Dare Bioscience position as of Q1 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 2 Dare Bioscience shares in Q1 2026, an estimated $4.
  • Cornerstone Planning Group first reported a position in Dare Bioscience in Q3 2023 and held it in 9 quarters.
  • Cornerstone Planning Group's Dare Bioscience position peaked at $38.8K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on Cornerstone Planning Group's 13F filing for Q1 2026, filed 6 May 2026.